IBM Stock Before Q3 Earnings Release: To Buy or Not to Buy?
IBM Stock Before Q3 Earnings Release: To Buy or Not to Buy? The Globe and Mail
Covered in this story
Analyst targets on IBM
- UBS: $231 → $236 by Oct 2027 · Neutral via Investing.com
- Truist Securities: $227 → $240 by Oct 2027 via Pluang
- Barclays: $234 → $350 by Aug 2027 · Overweight via foreignpolicyjournal.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IBM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on IBM →Also covered by 1 other outlet
Dalsna Finance is currently tracking 50 stories mentioning IBM, the earliest published 20 Jul 2026.
Summary aggregated from The Globe and Mail's public RSS feed. The full reporting belongs to The Globe and Mail — please read it on their site.